Severe acute respiratory syndrome (SARS) coronavirus-2 infection (COVID-19) in pregnancy – An overview
| Autor: | Mariam Al Beloushi, Justin C. Konje, Wafaa Ali Belail Hammad, Badreleden Ahmed |
|---|---|
| Rok vydání: | 2021 |
| Předmět: |
myalgia
COVID-190 Pediatrics medicine.medical_specialty medicine.medical_treatment SARS-2 Disease Asymptomatic Full Length Article Ethnicity Sore throat Humans Lactation Medicine Caesarean section Pregnancy Complications Infectious Minority Groups Pregnancy Labor Obstetric Cesarean Section SARS-CoV-2 business.industry Pregnancy Outcome Anticoagulants COVID-19 Obstetrics and Gynecology Venous Thromboembolism vaccination medicine.disease Infectious Disease Transmission Vertical Coronavirus Reproductive Medicine Female vertical transmission Severe acute respiratory syndrome pregnancy medicine.symptom business Breast feeding |
| Zdroj: | European Journal of Obstetrics, Gynecology, and Reproductive Biology |
| ISSN: | 0301-2115 |
| DOI: | 10.1016/j.ejogrb.2021.06.001 |
| Popis: | The novel severe acute respiratory syndrome (SARS) coronavirus-2 which causes COVID-19 disease results in severe morbidity and mortality especially in vulnerable groups. Pregnancy by virtue of its physiological and anatomical adaptations increases the risk of severe infections especially those of the respiratory tract. This single stranded RNA virus is transmitted by droplets as well as soiled fomites. There are various degrees of disease severity– asymptomatic, mild, moderate severe and critical. Most infections in pregnancy are asymptomatic or mildly symptomatic. For these women, the consequences on the mother or pregnancy are minimal unless they have additional risk factors such as diabetes, hypertension, cardiorespiratory disease, obesity or are of ethnic minority background. Most women with symptoms will present with fever, unproductive cough, sore throat, myalgia, nasal congestion, loss of smell and taste with associated leukocytosis and lymphopenia. Diagnosis is by RT-PCR on nasopharyngeal flocked swabs or saliva and pathognomonic features of ground-glass appearance and pulmonary infiltrates on chest X-ray or CT scans. Management in pregnancy is same as that for non-pregnant women with COVID-19. It is not an indication for elective delivery but assisted delivery in the second stage for those with moderate, severe or critical disease may be required to shorten this stage. COVID-19 is not an indication for interrupting pregnancy or caesarean section but the latter may be performed to facilitate ventilation support or resuscitation in those with severe disease. Pain relief in labour should not be different but regional analgesia is preferred for operative deliveries. Postpartum thromboprophylaxis should be considered and breast feeding encouraged with appropriate precautions to minimize vertical transmission. Pregnant and lactating women should be encouraged to receive vaccination as there is no evidence of adverse outcomes with currently available vaccines. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect